Cite
HARVARD Citation
Reich, K. et al. (n.d.). One‐year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate‐to‐severe plaque psoriasis. British journal of dermatology. pp. 435-444. [Online].